SCIENCE: Speech outcomes in Parkinson’s disease after subthalamic nucleus deep brain stimulation

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is effective in reducing motor symptoms for many individuals with Parkinson’s disease (PD). However, STN DBS does not appear to influence speech in the same way, and may result in a variety of negative outcomes for people with PD

 

Click here for more details.

Tags: , , ,

Related Post

Professor Angela Morgan leads the Translational Centre for Speech Disorders in groundbreaking NHMRC CRE research program

  • Posted on 14 September, 2023
    Redenlab, a leading provider of innovative solutions in the field of pediatric and neurodevelopment communication, proudly announces that Professor Angela...
    Read more

    Academic and patient advocacy group collaborations in Dentatorubral-pallidoluysian atrophy (DRPLA)

    • Posted on 11 August, 2023
      Dentatorubral-pallidoluysian atrophy (DRPLA) is a rare progressive brain disorder that can impact children and adults. In children, DRPLA can lead...
      Read more

      Redenlab shines in Huberman Podcast, unveiling cannabis study and speech analysis expertise

      • Posted on 27 April, 2023
        MEDIA RELEASERedenlab, a leading techbio company, proudly announces its recent feature on the highly acclaimed Huberman Podcast. The podcast episode...
        Read more